Literature DB >> 6087073

Cytomegalovirus hepatitis in normal and immune compromised hosts.

C H Ten Napel, H J Houthoff, T H The.   

Abstract

Liver biopsies of six previously normal hosts (Group I, NH), with recent or acute CMV infection, and autopsy liver samples of four immunocompromised hosts (Group II, ICH) with overwhelming CMV infection have been studied in an occasional survey. In both groups, portal tract involvement, bile duct inflammation, liver cell degeneration and parenchymal granulomas were present. In Group I, a randomly distributed hepatitis with predominant involvement of the periportal areas was present, including sinusoidal arrays of lymphocytes and lymphohistiocytic aggregates. In contrast, in Group II liver cell damage was more extensive and the inflammatory infiltration only scarce. Intracellular viral inclusion bodies were found only in Group II, both in liver cells and in bile duct epithelium. Morphologically, the presence of viral inclusion bodies correlated well with the immunohistologic demonstration of CMV specific "late" (CMV-LA) or structural antigens. In addition, CMV-specific "early" (CMV-EA) or non-structural antigens were present in liver cell nuclei of 2/6 NH and 2/4 ICH. The possible relations between the inflammation and the lack of structural antigenic viral expression are discussed. It is concluded that ICH with CMV infection have a prominent cytopathogenic effect and widespread lytic viral infection in the liver in the absence of adequate immunologic reactivity, whereas the opposite is found in NH.

Entities:  

Mesh:

Year:  1984        PMID: 6087073     DOI: 10.1111/j.1600-0676.1984.tb00926.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  16 in total

1.  Natural killer activity in patients with acute viral hepatitis.

Authors:  L Chemello; M Mondelli; F Bortolotti; E Schiavon; P Pontisso; A Alberti; E G Rondanelli; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

2.  Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage.

Authors:  Jing Zhang; Yujing Huang; Qing Wang; Yanping Ma; Ying Qi; Zhongyang Liu; Jingui Deng; Qiang Ruan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-20       Impact factor: 3.267

3.  AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients.

Authors:  Y Benhamou; E Caumes; Y Gerosa; J F Cadranel; E Dohin; C Katlama; P Amouyal; J M Canard; N Azar; C Hoang
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

4.  Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.

Authors:  Anna-Kathrin Schupp; Mirko Trilling; Stephanie Rattay; Vu Thuy Khanh Le-Trilling; Katrin Haselow; Jan Stindt; Albert Zimmermann; Dieter Häussinger; Hartmut Hengel; Dirk Graf
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

5.  Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis.

Authors:  C D Peacock; S D Olver; P Price
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 6.  Infectious diseases and the liver.

Authors:  Rohit Talwani; Bruce L Gilliam; Charles Howell
Journal:  Clin Liver Dis       Date:  2011-02       Impact factor: 6.126

7.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Histological diagnosis of cytomegalovirus hepatitis in liver allografts.

Authors:  F Colina; N T Jucá; E Moreno; C Ballestín; J Fariña; M Nevado; C Lumbreras; R Gómez-Sanz
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

9.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice.

Authors:  S D Olver; P Price; G R Shellam
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.